Company Filing History:
Years Active: 2025
Title: Akash Sohoni: Innovator in Chimeric Antigen Receptors
Introduction
Akash Sohoni is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of immunotherapy. His work primarily focuses on the development of chimeric antigen receptors (CARs) that enhance the efficacy of immune effector cells.
Latest Patents
Sohoni holds a patent for "Chimeric antigen receptors and uses thereof." This invention provides immune effector cells, such as T cells and NK cells, that express a chimeric antigen receptor. The patent outlines various compositions and methods for utilizing these immune cells in therapeutic applications.
Career Highlights
Currently, Akash Sohoni is associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to further his research and development efforts in the field of immunotherapy, contributing to innovative treatments for various diseases.
Collaborations
Sohoni collaborates with talented professionals in his field, including Aida Abujoub and John Blankenship. These collaborations enhance the research environment and foster innovation in the development of new therapies.
Conclusion
Akash Sohoni's work in the development of chimeric antigen receptors represents a significant advancement in immunotherapy. His contributions are paving the way for new treatment options that could improve patient outcomes in the future.